PharmaReports: Psychiatric, Addictive & Sleep Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel focuses on the main psychiatric diseases such as depression, bipolar disease, anxiety and schizophrenia although reports focusing on neuroelectrophysiology (for example epilepsy) are also included here. Likewise reports relating to addictive, sleep and attention deficit disorders are also included here.
Showing results 51 - 100 of 100
- Pediatric Drugs - the Worldwide Market
- Pipeline Insight: Substance Dependence - Nicotine
- Adult ADHD - Therapeutic Opportunities
- Insomnia - Wake-Up Call for a Sleepy Market
- Restless Legs Syndrome - Recognition Lacking Still
- Pipeline Insight: Depression - Novel therapies key to market penetration
- Stakeholder Insight: Anxiety Disorders - More Than Just a Comorbidity
- Pipeline Insight: Antipsychotics - Novel Antipsychotics Driving Market Evolution
- Stakeholder Insight: Bipolar Disorders - Zyprexa Sets the Mood for Revenue Growth
- Commercial Insight: Antidepressants - Sliding SSRI Revenues Inevitable
- Stakeholder Insight: ADHD - Prescriber Attention Still Held by Short Acting Stimulant Drugs
- Patient Compliance in Psychiatry - From Patient Acquisition to Patient Retention
- Commercial Insight: Antipsychotics - From Blockbuster Brands to Billion Dollar Generics
- The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being
- The Outlook for Niche CNS Disorders: Commercial opportunities in developing markets
- Innovations in CNS: Novel therapeutics and future R&D strategies
- Gene Expression Profiling Markets
- UpdatesPlus-Nicotinic Receptors (January 2008)
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Pipeline Insight: Substance Dependence - Alcohol
- Pipeline Insight: Substance Dependence - Part I: Nicotine
- Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs
- How to Conduct Clinical Trials in China
- UpdatesPlus-Nicotinic Receptors (February 2008)
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- CNS Market Overview - neurology, pain and psychiatry
- Neuronal Nicotinic Receptors - April 2008
- Commercial and Pipeline Insight: ADHD
- Outsourcing in Drug Discovery
- Sleep Disorders Market Analysis 2008-2018
- Antipsychotics Market Insight and Analysis 2008
- Neuronal Nicotinic Receptors - June 2008
- Monoclonal Antibodies Report: 2008 Update
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Neuronal Nicotinic Receptors - July 2008
- Diagnostics in Neurology - Predictive biomarkers expand drug revenues
- Neuronal Nicotinic Receptors - August 2008
- Neuronal Nicotinic Receptors - September 2008
- The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Ion Channel Trends 2008
- GPCR Screening & Profiling Trends 2008
- Neuronal Nicotinic Receptors - October 2008
- The Global Anti-Addiction Market, 2008-2023
- The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- The Future of RNAi Therapeutics: Drug Pipelines and Prospects
< Previous1 | 2
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development